Viewing nowNewcota Tablets (Rebamipide)
Rebamipide 100mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

MFDS item code 200401582 · Notified 2004.08.09 · Insurance code 665500350
Improvement of gastric ulcers and gastric mucosal lesions (erosion, bleeding, etc.)
This medication is used for the treatment of gastric ulcers. It also helps improve the symptoms such as erosion, bleeding, redness, and swelling of the gastric mucosa that occur during acute exacerbations of acute or chronic gastritis. Therefore, it is effective in protecting the gastric mucosa and alleviating the symptoms of gastric-related diseases.
Administer 100 mg of Rebamipide orally three times a day. However, for gastric ulcers, it should be taken in the morning, evening, and at bedtime.
This medication should not be used in patients who have had an allergic reaction to any component of this medication. During treatment with this medication, rare cases of shock or serious allergic reactions may occur, so if symptoms develop, treatment should be stopped immediately and medical attention sought. Additionally, white blood cell or platelet counts may decrease, so blood tests should be conducted periodically to monitor the condition. Liver function may become compromised, leading to jaundice or an increase in liver enzyme levels, so liver health should also be monitored closely. If allergic symptoms such as hives, rash, or itching appear on the skin, the medication should be discontinued. This medication may cause neurological symptoms such as dizziness, drowsiness, and numbness, so caution is needed when driving or operating machinery. Gastrointestinal disturbances such as indigestion, nausea, vomiting, diarrhea, and abdominal pain may occur, and if symptoms are severe, a physician should be consulted. Women who are pregnant or may become pregnant should use this medication cautiously, as its safety is not established. Nursing mothers should avoid breastfeeding, as this medication may be transmitted in breast milk. Safety in children, low-birth-weight infants, and newborns has not been sufficiently confirmed, so caution is necessary. Elderly patients may have diminished bodily functions and should be more alert to adverse effects such as gastrointestinal symptoms. This medication should be kept out of reach of children, and it is safer not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a tightly sealed container that blocks light. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius.
White round film-coated tablets
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRebamipide 100mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Korea Otsuka Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Sinphong Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Yuhan Corporation

Rebamipide 100mg
Tablet · Prescription medication
Jongkundang Corporation

Rebamipide 100mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.